Impact of targeted drug administration and intermittent preventive treatment for forest goers using artesunate-pyronaridine to control malaria outbreaks in Cambodia
- PMID: 38863067
- PMCID: PMC11165738
- DOI: 10.1186/s41182-024-00607-2
Impact of targeted drug administration and intermittent preventive treatment for forest goers using artesunate-pyronaridine to control malaria outbreaks in Cambodia
Abstract
Introduction: The national malaria programme of Cambodia targets the rapid elimination of all human malaria by 2025. As clinical cases decline to near-elimination levels, a key strategy is the rapid identification of malaria outbreaks triggering effective action to interrupt local transmission. We report a comprehensive, multipronged management approach in response to a 2022 Plasmodium falciparum outbreak in Kravanh district, western Cambodia.
Methods: The provincial health department of Pursat in conjunction with the Center for Parasitology, Entomology and Malaria Control (CNM) identified villages where transmission was occurring using clinical records, and initiated various interventions, including the distribution of insecticide-treated bed nets, running awareness campaigns, and implementing fever screening with targeted drug administration. Health stations were set up at forest entry points, and later, targeted drug administrations with artesunate-pyronaridine (Pyramax) and intermittent preventive treatment for forest goers (IPTf) were implemented in specific village foci. Data related to adherence and adverse events from IPTf and TDA were collected. The coverage rates of interventions were calculated, and local malaria infections were monitored.
Results: A total of 942 individuals were screened through active fever surveillance in villages where IPTf and TDA were conducted. The study demonstrated high coverage and adherence rates in the targeted villages, with 92% (553/600) coverage in round one and 65% (387/600) in round two. Adherence rate was 99% (551/553) in round one and 98% (377/387) in round two. The study found that forest goers preferred taking Pyramax over repeated testing consistent with the coverage rates: 92% in round one compared to 65% in round two. All individuals reachable through health stations or mobile teams reported complete IPTf uptake. No severe adverse events were reported. Only six individuals reported mild adverse events, such as loss of energy, fever, abdominal pain, diarrhoea, and muscle aches. Two individuals attributed their symptoms to heavy alcohol intake following prophylaxis.
Conclusions: The targeted malaria outbreak response demonstrated high acceptability, safety, and feasibility of the selected interventions. Malaria transmission was rapidly controlled using the available community resources. This experience suggests the effectiveness of the programmatic response for future outbreaks.
Keywords: Artesunate–pyronaridine; Cambodia; Intermittent preventive treatment; Outbreak response, forest goers; Targeted drug administration.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Malaria elimination challenges in countries approaching the last mile: a discussion among regional stakeholders.Malar J. 2024 Dec 26;23(1):401. doi: 10.1186/s12936-024-05215-3. Malar J. 2024. PMID: 39722002 Free PMC article. Review.
-
Intermittent preventive treatment for forest goers by forest malaria workers: an observational study on a key intervention for malaria elimination in Cambodia.Lancet Reg Health West Pac. 2024 May 17;47:101093. doi: 10.1016/j.lanwpc.2024.101093. eCollection 2024 Jun. Lancet Reg Health West Pac. 2024. PMID: 38799614 Free PMC article.
-
An innovative three-layer strategy in response to a quartan malaria outbreak among forest goers in Hainan Island, China: a retrospective study.Infect Dis Poverty. 2022 Sep 14;11(1):97. doi: 10.1186/s40249-022-01015-6. Infect Dis Poverty. 2022. PMID: 36104737 Free PMC article.
-
Choosing interventions to eliminate forest malaria: preliminary results of two operational research studies inside Cambodian forests.Malar J. 2021 Jan 20;20(1):51. doi: 10.1186/s12936-020-03572-3. Malar J. 2021. PMID: 33472630 Free PMC article.
-
How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature.Malar J. 2019 Feb 1;18(1):32. doi: 10.1186/s12936-019-2666-5. Malar J. 2019. PMID: 30709399 Free PMC article.
Cited by
-
How do study participants want to be informed about study results: Findings from a malaria trial in Cambodia, Ethiopia, Pakistan, and Indonesia.J Clin Transl Sci. 2025 Mar 27;9(1):e83. doi: 10.1017/cts.2025.56. eCollection 2025. J Clin Transl Sci. 2025. PMID: 40391130 Free PMC article.
-
Malaria elimination challenges in countries approaching the last mile: a discussion among regional stakeholders.Malar J. 2024 Dec 26;23(1):401. doi: 10.1186/s12936-024-05215-3. Malar J. 2024. PMID: 39722002 Free PMC article. Review.
References
-
- CNM. National Treatment Guidelines for Malaria in Cambodia. 2022. https://bit.ly/3UkDaV7. Accessed 2 May 2024.
-
- WHO: Mekong malaria elimination: epidemiology summary, volume 23, July–September 2023. https://bit.ly/3JJ5CLn. Accessed 2 May 2024.
-
- Sattabongkot J, Cui L, Bantuchai S, Chotirat S, Kaewkungwal J, Khamsiriwatchara A, Kiattibutr K, Kyaw MP, Lawpoolsri S, Linn NYY. Malaria research for tailored control and elimination strategies in the Greater Mekong Subregion. Am J Trop Med Hyg. 2022;107:152. doi: 10.4269/ajtmh.21-1268. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials